- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04697745
Dexamethasone and Dexmedetomidine as an Adjuvant to Spinal Anesthesia for Elective Caesarean Sections
January 5, 2021 updated by: Baher Said Elshahat Mohamed Abdelhady, Benha University
Comparison Between Analgesic Effect of Dexamethasone and Dexmedetomidine as an Adjuvant to Bupivacaine for Spinal Anesthesia for Elective Caesarean Sections
The main objective of our study is to evaluate analgesic effect of intrathecal dexamethasone and dexmedetomidine in elective caesarean sections
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
44
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 36 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- American Society of Anesthesiologists classII-III adult female patient (age :18 -40 years old )
- Elective cesarean section under spinal anaesthesia
- Gestational age > 37 weeks
- BMI less than 30 kg/m2
Exclusion Criteria:
- Patient refusal
- unable to give consent
- age < 18 or > 40
- BMI more than 30 kg/m2
- known allergy to the study medication
- coagulopathies or on anticoagulant medications
- diabetic neuropathy
- patients with psychiatric disorders
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: dexamethasone intrathecal
|
intrathecal adjuvants to bupivacaine
|
|
Active Comparator: dexmedetomidine intrathecal
|
intrathecal adjuvants to bupivacaine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
analgesic effect
Time Frame: Up to 24 hours after surgery
|
Duration of sensory block and time to first analgesic rescue . . |
Up to 24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
intraoperative complications
Time Frame: during surgery
|
Incidince of intraoperative shivering, nausea and vometing
|
during surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
March 1, 2021
Primary Completion (Anticipated)
April 30, 2021
Study Completion (Anticipated)
May 30, 2021
Study Registration Dates
First Submitted
January 4, 2021
First Submitted That Met QC Criteria
January 5, 2021
First Posted (Actual)
January 6, 2021
Study Record Updates
Last Update Posted (Actual)
January 6, 2021
Last Update Submitted That Met QC Criteria
January 5, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Postoperative Complications
- Pain
- Neurologic Manifestations
- Pain, Postoperative
- Physiological Effects of Drugs
- Adrenergic Agents
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Autonomic Agents
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antiemetics
- Gastrointestinal Agents
- Glucocorticoids
- Hormones
- Hormones, Hormone Substitutes, and Hormone Antagonists
- Antineoplastic Agents, Hormonal
- Adrenergic alpha-2 Receptor Agonists
- Adrenergic alpha-Agonists
- Adrenergic Agonists
- Hypnotics and Sedatives
- Dexamethasone
- Dexmedetomidine
Other Study ID Numbers
- adjuvant to spinal anesthesia
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pain, Postoperative
-
National and Kapodistrian University of AthensCompletedPostoperative Pain, Acute | Postoperative Pain, Chronic | Postoperative Pain After Thoracic SurgeryGreece
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPostoperative Pain | Postoperative Pain Management | Postoperative Pain in Orthopaedics
-
University of MalayaActive, not recruitingPostoperative Pain | Postoperative Pain ManagementMalaysia
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Bezmialem Vakif UniversityRecruitingPostoperative Pain ManagementTurkey
-
Pacira Pharmaceuticals, IncCompletedPostoperative Pain ManagementUnited States
Clinical Trials on Intrathecal dexamethasone
-
Princess Maxima Center for Pediatric OncologyAbbVie; AstraZenecaNot yet recruitingAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent | Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Refractory | Lymphoblastic...
-
Hee Young JuSeoul St. Mary's Hospital; Asan Medical Center; Chonnam National University Hospital and other collaboratorsRecruitingLymphoblastic Leukemia in ChildrenKorea, Republic of
-
Tisch Multiple Sclerosis Research Center of New...CompletedMultiple SclerosisUnited States
-
Moens MaartenCompleted
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
International Stemcell Services LimitedCompletedSpinal Cord InjuriesIndia
-
Universitaire Ziekenhuizen KU LeuvenActive, not recruitingAnalgesia | Nausea and Vomiting, Postoperative | Morphine | Morphine Adverse Reaction | Morphine Induced Pruritis | Spinal AnalgesiaBelgium
-
Royan InstituteCompletedAmyotrophic Lateral SclerosisIran, Islamic Republic of
-
RJK Biopharma LtdPeking University Third HospitalActive, not recruitingAmyotrophic Lateral Sclerosis AlsChina
-
RJK Biopharma LtdActive, not recruitingAmyotrophic Lateral SclerosisChina